HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Armando Luaña Selected Research

Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)

3/2015Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia.
1/2013Severe thrombocytopenia related to long-term trastuzumab exposure.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Armando Luaña Research Topics

Disease

2Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
03/2015 - 01/2013
1Diarrhea
03/2015
1Thrombosis (Thrombus)
03/2015
1Thrombocytopenia (Thrombopenia)
01/2013

Drug/Important Bio-Agent (IBA)

1eltrombopagFDA Link
03/2015
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
03/2015
1Inosine Triphosphate (ITP)IBA
03/2015
1Monoclonal AntibodiesIBA
01/2013
1Trastuzumab (Herceptin)FDA Link
01/2013
1Pharmaceutical PreparationsIBA
01/2013